Comparison of Effectiveness and Safety of Drug-Eluting Stents Versus Vascular Brachytherapy for Saphenous Vein Graft In-Stent Restenosis

American Journal of Cardiology

Volumn 97, Issue 9, 2006, Pages 1303-1307

  Mishra, Sundeep ^a   Wolfram, Roswitha M ^a   Torguson, Rebecca ^a   Chu, William W ^a   Xue, Zhenyi ^a   Gevorkian, Natalie ^a   Donekal, Sirisha ^a   Chan, Rosanna ^a   Pichard, Augusto D ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CLINICAL FEATURE; CORONARY STENT; CORRELATION ANALYSIS; DRUG ELUTING STENT; FEMALE; GAMMA IRRADIATION; HEART INFARCTION; HEART INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; Q WAVE; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHYTHERAPY; CASE-CONTROL STUDIES; CORONARY CIRCULATION; DRUG DELIVERY SYSTEMS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS;

EID: 33646032101     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.064     Document Type: Article

References (21)

1. Bourassa M.G., Fisher L.D., Campeau L., Gillespie M.J., McConney M., and Lesperance J. Long-term fate of bypass grafts. the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute Experiences. Circulation 72 suppl (1985) V-71-V-78
2. Foster E.D., Fisher L.D., Kaiser G.C., Myers W.O., Carpenter J., Abele S., and Ells R. Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting. the Coronary Artery Surgery Study (CASS) registry experience. Ann Thorac Surg 38 (1984) 563-570
3. Savage M.P., Douglas Jr. J.S., Fischman D.L., Pepine C.J., King III S.B., Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., et al., Saphenous Vein De Novo Trial Investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 337 (1997) 740-747
4. Waksman R., Ajani A.E., White R.L., Chan R.C., Satler L.F., Kent K.M., Pichard A.D., Pinnow E.E., Bui A.B., Ramee S., et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 346 (2002) 1194-1199
5. Nag S., Dally M., de la Torre M., Tatsuzaki H., Kizilbash N., Kurusun S., Pinillos L., Pokrajac B., Sur R., and Levin V. Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency. Radiother Oncol 64 (2002) 297-308
6. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al., RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I. six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
8. Fattori R., and Piva T. Drug-eluting stents in vascular intervention. Lancet 361 (2003) 247-249
9. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., Schomig A., and ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis. a randomized controlled trial. JAMA 293 (2005) 165-171
10. Waksman R., White R.L., Chan R.C., Bass B.G., Geirlach L., Mintz G.S., Satler L.F., Mehran R., Serruys P.W., Lansky A.J., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 101 (2000) 2165-2171
11. Ellis S.G., Vandormael M.G., Cowley M.J., DiSciascio G., Deligonul U., Topol E.J., Bulle T.M., and Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Circulation 82 (1990) 1193-1202
12. Waksman R., Bhargava B., White L., Chan R.C., Mehran R., Lansky A.J., Mintz G.S., Satler L.F., Pichard A.D., Leon M.B., and Kent K.K. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 101 (2000) 1895-1898
13. Stone G.W., Mehran R., Midei M., Waksman R., Schaer G.L., Negoita M., Lansky A.J., Buchbinder M., and SVG BRITE Investigators. Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol 92 (2003) 312-314
14. Werner G.S., Emig U., Krack A., Schwarz G., and Figulla H.R. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis. Catheter Cardiovasc Interv 63 (2004) 259-264
15. Cicek D., Doven O., Pekdemir H., Camsari A., Akkus N.M., Cin G.V., Parmaksiz T., and Katircibasi T. Procedural results and distal embolization after saphenous vein graft stenting and angioplasty for in-stent restenosis of grafts. Jpn Heart J 45 (2004) 561-571
16. Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., et al., SES-SMART Investigators. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries. a randomized trial. JAMA 292 (2004) 2727-2734
17. Schofer J., Bode C., and Silber S. Drug-eluting stents for in-stent restenosis and acute myocardial infarction. present data from nonrandomized studies. Herz 29 (2004) 195-200
18. Chieffo A., Stankovic G., Bonizzoni E., Tsagalou E., Iakovou I., Montorfano M., Airoldi F., Michev I., Sangiorgi M.G., Carlino M., et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111 (2005) 791-795
19. Flaherty J.D., and Davidson C.J. Diabetes and coronary revascularization. JAMA 293 (2005) 1501-1508
20. Werner G.S., Krack A., Schwarz G., Prochnau D., Betge S., and Figulla H.R. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 44 (2004) 2301-2306
21. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., et al. Treatment of saphenous vein graft lesions with drug-eluting stents immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 989-994